Prevalence, predictors and prognostic value of acute impairment in renal function during intensive unloading therapy in a community population hospitalized for decompensated heart failure

Journal of Cardiovascular Medicine

Volumn 8, Issue 6, 2007, Pages 419-427

  Cioffi, Giovanni ^a,g   Tarantini, Luigi ^b   Pulignano, Giovanni ^c   Sindaco, Donatella Del ^d   Feo, Stefania De ^e   Opasich, Cristina ^e   Dilenarda, Andrea ^f   Stefenelli, Carlo ^a   Furlanello, Francesco ^a  

^a Department of Cardiology   (Italy)

^b SAN MARTINO HOSPITAL   (Italy)

^c SAN CAMILLO FORLANINI HOSPITAL   (Italy)

^d INRCA   (Italy)

^e IRCCS   (Italy)

^f 'Riuniti' Hospital   (Italy)

^g Villa Bianca Hospital   (Italy)

Author keywords

Chronic heart failure; Elderly population; Renal dysfunction; Unloading therapy

Indexed keywords

CARVEDILOL; CREATININE; DIGITALIS; DOPAMINE; ENALAPRIL; FUROSEMIDE; ISOSORBIDE DINITRATE; NITROPRUSSIDE SODIUM; SPIRONOLACTONE;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; COMMUNITY HOSPITAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG DOSE TITRATION; FEMALE; HEART FAILURE; HOSPITAL PATIENT; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; DIURETICS; FUROSEMIDE; HEART FAILURE, CONGESTIVE; HOSPITALS, COMMUNITY; HUMANS; NITROPRUSSIDE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY; RISK FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 34248640551     PISSN: 15582027     EISSN: None     Source Type: Journal    
DOI: 10.2459/01.JCM.0000269715.95317.33     Document Type: Article

References (39)

1. Krumholz HM, Chen YT, Vaccarino V, Wang Y, Radford MJ, Bradford WD, Horwitz RI. Correlates and impact on outcomes of worsening renal function in patients > or = 65 years of age with heart failure. Am J Cardiol 2000; 85:1110-1113.
2. Smilde TD, Hillege HL, Navis G, Boomsma F, de Zeeuw D, van Veldhuisen DJ. Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival. Am Heart J 2004; 148:165-172.
3. Silverberg D, Wexler D, Blum M, Schwartz D, Iaina A. The association between congestive heart failure and chronic renal disease. Curr Opin Nephrol Hypertens 2004; 13:163-170.
4. Gottlieb SS, Abraham W, Butler J, Forman DE, Loh E, Massie BM, et al. The prognostic importance of different definitions of worsening renal function in congestive heart failure. J Card Fail 2002; 8:136-141.
5. Wexler DJ, Chen J, Smith GL, Radford MJ, Yaari S, Bradford WD, Krumholz HM. Predictors of costs of caring for elderly patients discharged with heart failure. Am Heart J 2001; 142:350-357.
6. Mahon NG, Blackstone EH, Francis GS, Starling RC III, Young JB, Lauer MS. The prognostic value of estimated creatinine clearance alongside functional capacity in ambulatory patients with chronic congestive heart failure. J Am Coll Cardiol 2002; 40:1106-1113.
7. Schoolwerth AC, Sica DA, Ballermann BJ, Wilcox CS, Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation 2001; 104:1985-1991.
8. Butler J, Forman DE, Abraham WT, Gottlieb SS, Loh E, Massie BM, et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am Heart J 2004; 147:331-338.
9. Weinfeld MS, Chertow GM, Stevenson LW. Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure. Am Heart J 1999; 138:285-290.
10. Capomolla S, Pozzoli M, Opasich C, Febo O, Riccardi G, Salvucci F, et al. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function. Am Heart J 1997; 134:1089-1098.
11. Stevenson LW, Tillisch JH, Hamilton M, Luu M, Chelimsky-Fallick C, Moriguchi J, et al. Importance of hemodynamic response to therapy in predicting survival with ejection fraction less than or equal to 20% secondary to ischemic or nonischemic dilated cardiomyopathy. Am J Cardiol 1990; 66:1348-1354.
12. Stevenson LW, Bellil D, Grover-McKay M, Brunken RC, Schwaiger M, Tillisch JH, Schelbert HR. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 1987; 60:654-658.
13. Cioffi G, Stefenelli C, Tarantini L, Opasich C. Hemodynamic response to intensive unloading therapy (furosemide and nitroprusside) in patients >70 years of age with left ventricular systolic dysfunction and decompensated chronic heart failure. Am J Cardiol 2003; 92:1050-1056.
14. Senni M, Tribouilloy CM, Rodeheffer RJ, Jacobsen SJ, Evans JM, Bailey KR, Redfield MM. Congestive heart failure in the community: a study of all incident cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98:2282-2289.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40:373-383.
16. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16:31-41.
17. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. Recommendations for quantitation of the left ventricle by twodimensional echocardiography. J Am Soc Echocardiograph 1989; 2:358.
18. Lester SJ, Ryan EW, Schiller NB, Foster E. Best method in clinical practice and in research studies to determine left atrial size. Am J Cardiol 1999; 84:829-832.
19. Miyatake K, Izumi S, Okamoto M, Kinoshita N, Asonuma H, Nakagawa H, et al. Semiquantitative grading of severity of mitral regurgitation by real time two dimensional Doppler flow imaging technique. J Am Coll Cardiol 1986; 7:82-88.
20. Pozzoli M, Capomolla S, Pinna G, Cobelli F, Tavazzi L. Doppler echocardiography reliably predicts pulmonary artery wedge pressure in patients with chronic heart failure with and without mitral regurgitation. J Am Coll Cardiol 1996; 27:883-893.
21. Temporelli PL, Scapellato F, Corra U, Eleuteri E, Imparato A, Giannuzzi P. Estimation of pulmonary wedge pressure by transmitral Doppler in patients with chronic heart failure and atrial fibrillation. Am J Cardiol 1999; 83:724-727.
22. Capomolla S, Febo O, Caporotondi A, Guazzotti G, Gnemmi M, Rossi A, et al. Non-invasive estimation of right atrial pressure by combined Doppler echocardiographic measurements of the inferior vena cava in patients with congestive heart failure. Ital Heart J 2000; 1:684-690.
23. Cioffi G, Stefenelli C, Tarantini L, Opasich C. Prevalence, predictors and prognostic implications of improvement in left ventricular systolic function and clinical status in patients >70 years of age with recently diagnosed systolic heart failure. Am J Cardiol 2003; 92:166-172.
24. Tarantini L, Cioffi G, Opasich C, Di Lenarda A, Pulignano G, Del Sindaco D, et al. Pre-discharge initiation of beta-blocker therapy in elderly patients hospitalized for acute decompensation of chronic heart failure: an effective strategy for the implementation of beta-blockade in heart failure. Ital Heart J 2004; 5:441-449.
25. Levy EM, Viscoli CM, Horowitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996; 275:1489-1494.
26. Culleton BP, Larson MG, Wilson PW, Evans JC, Parfrey PS, Levy D. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int 1999; 56:2214-2219.
27. Guyton AC, Cowley AW Jr, Young DB, Coleman TG, Hall JE, DeClue JW. Integration and control of circulatory function. Int Rev Physiol 1976; 9:341-385.
28. Bongartz LG, Cramer MJ, Doevendans PA, Joles JA, Braam B. The severe cardiorenal syndrome: 'Guyton revisited'. Eur Heart J 2005; 26:11-17.
29. Sarnak MJ, Levey AS, Schoolwerth AC, Coresh J, Culleton B, Hamm LL, et al., for the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 2003; 42:1050-1065.
30. Lapman PG, Golduber GN, Le Jemtel TH. Heart failure treatment and renal function. Am Heart J 2004; 147:193-194.
31. Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J Am Soc Nephrol 2003; 14:2178-2187.
32. Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick SG, Krumholz HM. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 2003; 9:13-25.
33. Akhter MW, Aronson D, Bitar F, Khan S, Singh H, Singh RP, et al. Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. Am J Cardiol 2004; 94:957-960.
34. Mehta RL, Pascual MT, Soroko S, Chertow GM, PICARD Study Group. Diuretics, mortality, and nonrecovery of renal function in acute renal failure. JAMA 2002; 288:2547-2553.
35. Greither A, Goldman S, Edelen JS, Greither A, Goldman S, Edelen JS, et al. Pharmacokinetics of furosemide in patients with congestive heart failure. Pharmacology 1979; 19:121-131.
36. Beermann B. Aspects of pharmacokinetics of some diuretics. Acta Pharmacol Toxicol 1984; 54 (Suppl 1):17-29.
37. Johnson W, Omland T, Hall C, Lucas C, Myking OL, Collins C, et al. Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 2002; 39:1623-1629.
38. Bart BA, Goldsmith SR. Aggravated renal dysfunction and the acute management of advanced chronic heart disease. Am Heart J 1999; 138:200-202.
39. Shlipak MG, Massie BM. The clinical challenge of cardiorenal syndrome. Circulation 2004; 110:1514-1517.